Finn Hansen

Prof. Dr. Finn Hansen is a Professor of Pharmacy at the University of Bonn, affiliated with the Department of Pharmacy. His research focuses on developing novel chemical tools to combat chemoresistance in cancer, particularly through the design of selective histone deacetylase (HDAC) inhibitors, protein-protein interaction inhibitors, and chimeric small molecules like PROTACs. The Hansen Group employs advanced synthetic methodologies including solid-phase and microwave-assisted synthesis to create innovative therapeutic compounds.

Research Interests:

• Medicinal Chemistry
• Epigenetic Modulation
• PROTAC Technology
• Cancer Pharmacology
• Multi-Target Drug Design

Laboratory Activities: The group specializes in synthesizing small molecules and peptidomimetics, followed by biological evaluation in target-based and phenotypic assays to analyze structure-activity relationships. Their work bridges synthetic chemistry and translational oncology, with a focus on overcoming treatment resistance mechanisms.